{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:45:59Z","timestamp":1789908359303,"version":"4.0.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["164587"],"award-info":[{"award-number":["164587"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust","award":["170461"],"award-info":[{"award-number":["170461"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1093\/jac\/dkw343","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T14:10:29Z","timestamp":1479391829000},"page":"3487-3494","source":"Crossref","is-referenced-by-count":25,"title":["HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK"],"prefix":"10.1093","volume":"71","author":[{"given":"Kate","family":"El Bouzidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Mbisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Sabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton L.","family":"Pozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tostevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deenan","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,9,28]]},"reference":[{"key":"2016111706102017000_71.12.3487.1","unstructured":"British HIV Association. British HIV Association Guidelines for the Treatment of HIV-1-Positive Adults With Antiretroviral Therapy 2015 . http:\/\/www.bhiva.org\/documents\/Guidelines\/Treatment\/2015\/2015-treatment-guidelines.pdf ."},{"key":"2016111706102017000_71.12.3487.2","unstructured":"European AIDS Clinical Society. EACS Guidelines Version 8.0. October 2015. http:\/\/www.eacsociety.org\/files\/2015_eacsguidelines_8_0-english_rev-20160124.pdf ."},{"key":"2016111706102017000_71.12.3487.3","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services. http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultandAdolescentGL.pdf ."},{"key":"2016111706102017000_71.12.3487.4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01184-07"},{"key":"2016111706102017000_71.12.3487.5","first-page":"132","article-title":"2015 Update of the drug resistance mutations in HIV-1","volume":"23","author":"Wensing","year":"2015","journal-title":"Top Antivir Med"},{"key":"2016111706102017000_71.12.3487.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60497-8"},{"key":"2016111706102017000_71.12.3487.7","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2652-11-S1-P24"},{"key":"2016111706102017000_71.12.3487.8","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832cbcec"},{"key":"2016111706102017000_71.12.3487.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2012.01060.x"},{"key":"2016111706102017000_71.12.3487.10","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv465"},{"key":"2016111706102017000_71.12.3487.11","doi-asserted-by":"publisher","DOI":"10.1086\/432763"},{"key":"2016111706102017000_71.12.3487.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2004.00197.x"},{"key":"2016111706102017000_71.12.3487.13","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp455"},{"key":"2016111706102017000_71.12.3487.14","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bti607"},{"key":"2016111706102017000_71.12.3487.15","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq429"},{"key":"2016111706102017000_71.12.3487.16","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bti079"},{"key":"2016111706102017000_71.12.3487.17","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msi105"},{"key":"2016111706102017000_71.12.3487.18","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/mst030"},{"key":"2016111706102017000_71.12.3487.19","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msp077"},{"key":"2016111706102017000_71.12.3487.20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl855"},{"key":"2016111706102017000_71.12.3487.21","unstructured":"Stanford University. HIV Drug Resistance Database . http:\/\/hivdb.stanford.edu\/cgi-bin\/MutPrevBySubtypeRx.cgi ."},{"issue":"Suppl 19","key":"2016111706102017000_71.12.3487.22","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1471-2105-16-S19-S10","article-title":"Structural studies on molecular mechanisms of nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease","volume":"16","author":"Gupta","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"2016111706102017000_71.12.3487.23","unstructured":"FDA Prezista (Darunavir) Full Prescribing Information 2015 . http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/021976s036,202895s013lbl.pdf ."},{"key":"2016111706102017000_71.12.3487.24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328345ee95"},{"key":"2016111706102017000_71.12.3487.25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328307f24a"},{"key":"2016111706102017000_71.12.3487.26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00160-10"},{"key":"2016111706102017000_71.12.3487.27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr569"},{"key":"2016111706102017000_71.12.3487.28","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02356-08"},{"key":"2016111706102017000_71.12.3487.29","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283398216"},{"key":"2016111706102017000_71.12.3487.30","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-9-63"},{"key":"2016111706102017000_71.12.3487.31","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.055624-0"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/12\/3487\/8232380\/dkw343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T09:46:47Z","timestamp":1589708807000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,28]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,11,16]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1093\/jac\/dkw343"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw343","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,28]]}}}